Timothy McCarthy | LifeSci Advisors |
Sergio Traversa | CEO & Director |
Charles Ence | Chief Accounting & Compliance Officer |
Charles Gorodetzky | Former Scientific Director, National Institute of Drug Abuse Addiction Research Center |
Marc Goodman | SVB Leerink |
Andrea Tan | Goldman Sachs Group |
Joon Lee | Truist Securities |
Jay Olson | Oppenheimer |
Eddie Hickman | Guggenheim Securities |
Andrew Tsai | Jefferies |
Thank you for standing by. This is the conference operator. Welcome to the Relmada Therapeutics Second Quarter 2021 Earnings Call. [Operator Instructions]. I would now like to turn the conference over to Mr.